INTRODUCTION TO TARSAL TUNNEL SYNDROME MANAGEMENT
Tarsal tunnel syndrome (TTS) represents a complex entrapment neuropathy of the posterior tibial nerve or its branches within the fibro-osseous tunnel beneath the flexor retinaculum on the medial aspect of the ankle. The management of this condition demands a rigorous, evidence-based approach, balancing the biomechanical and physiological etiologies of nerve compression against the historically unpredictable outcomes of surgical decompression.
Unlike carpal tunnel syndrome, where surgical release yields reliably excellent outcomes, tarsal tunnel release is fraught with variable results. Consequently, the orthopedic surgeon must exercise profound clinical judgment, exhausting non-operative modalities and applying stringent patient selection criteria before proceeding to operative intervention.
NON-OPERATIVE MANAGEMENT
The cornerstone of initial treatment for tarsal tunnel syndrome is a comprehensive, non-operative regimen. A minimum of 6 to 12 weeks of dedicated conservative therapy is mandatory before considering surgical release, except in the presence of an acute, rapidly progressive neurological deficit or a massive space-occupying lesion (e.g., ganglion cyst, schwannoma, or lipoma).
Immobilization and Orthotic Management
Initial conservative management focuses on reducing mechanical tension and dynamic compression across the posterior tibial nerve.
* Ankle Immobilization: The use of a night splint to maintain the ankle in a neutral position prevents the extreme dorsiflexion and eversion that naturally occurs during sleep, thereby minimizing traction on the nerve.
* Footwear Modifications: Patients should be transitioned into wide, cushioned, and comfortable footwear. Rigid, narrow shoes exacerbate compression by increasing extrinsic pressure on the medial hindfoot.
* Biomechanical Correction: If hindfoot valgus is present and supple, the resulting eversion of the calcaneus places significant traction on the tibial nerve. The addition of a medial heel and sole wedge, or a custom orthosis with a medial post, is highly reasonable. This intervention inverts the hindfoot, effectively relaxing the flexor retinaculum and decreasing the longitudinal tension on the neurovascular bundle.
Pharmacotherapy
Anti-inflammatory agents (NSAIDs) are recommended to reduce perineural inflammation and tenosynovitis of the adjacent posterior tibial, flexor digitorum longus, and flexor hallucis longus tendons. In cases of severe neuropathic pain, neuromodulators such as gabapentin or pregabalin may be utilized as adjuncts.
Special Populations: Pregnancy
During pregnancy, patients frequently present with symptoms of tarsal tunnel syndrome secondary to physiological fluid retention and relaxin-induced ligamentous laxity, which leads to acquired pes planus.
Clinical Pearl: Treatment for pregnant patients should be strictly conservative, consisting of rest, elevation of the lower extremities, and the use of compression stockings. Observation for several weeks after delivery is the standard of care, as symptoms typically resolve spontaneously postpartum—mirroring the natural history of pregnancy-induced carpal tunnel syndrome and interdigital neuromas.
SURGICAL INDICATIONS AND CONTRAINDICATIONS
When conservative measures fail, surgical decompression may be considered. However, the decision to operate must be approached with extreme caution.
High-Risk Patient Profiles
Caution is strongly recommended when advising surgical treatment for tarsal tunnel syndrome in the following patient populations:
1. Older Patients (60 to 80 years old): Advanced age is often associated with microvascular insufficiency, peripheral neuropathy, and "double crush" phenomena (e.g., concurrent lumbar radiculopathy), which severely blunt the efficacy of a peripheral release.
2. Posttraumatic Scarring: Patients with a history of severe ankle trauma (e.g., calcaneal or pilon fractures) often possess dense, unyielding scar tissue within the tarsal canal. Surgical release in these cases is technically demanding and frequently yields poor results due to intraneural fibrosis.
3. Idiopathic Presentations: Patients in whom no objective cause for symptoms can be identified (e.g., no space-occupying lesion, no severe biomechanical deformity) have historically poor surgical outcomes.
4. Protracted Psychiatric Illness: Chronic pain syndromes complicated by psychiatric overlays (e.g., severe depression, somatization disorders) are relative contraindications, as central sensitization often renders peripheral decompression ineffective.
Prognostic Factors and Patient Counseling
Fewer than half of patients benefit significantly after the release of the flexor retinaculum. Even when a definitive space-occupying lesion is identified on preoperative MRI, only marginal improvement may be obtained.
Surgical Warning: Particular caution is recommended in patients presenting with concomitant plantar fasciitis or systemic inflammatory disease (e.g., rheumatoid arthritis). The overlapping pain generators in plantar fasciitis can confound the diagnosis and lead to perceived surgical failure.
According to landmark outcome studies by Sammarco and Chang, patients achieved an average improvement of only 19 points on a 100-point scale at an average of 58 months following tarsal tunnel release. Crucially, the patients who demonstrated the most significant postoperative improvement were those who had experienced symptoms for less than 1 year prior to treatment. This underscores the importance of timely intervention once conservative measures have definitively failed, preventing irreversible axonal damage.
SURGICAL ANATOMY AND BIOMECHANICS
A profound understanding of the medial ankle anatomy is non-negotiable for successful tarsal tunnel release. The tarsal tunnel is a fibro-osseous space bordered laterally by the medial surface of the talus, the sustentaculum tali, and the medial wall of the calcaneus. The medial roof is formed by the flexor retinaculum (laciniate ligament).
The Neurovascular Bundle
The contents of the tunnel, from anterior to posterior, are the tibialis posterior tendon, flexor digitorum longus tendon, posterior tibial artery and veins, tibial nerve, and flexor hallucis longus tendon (Tom, Dick, AND Very Nervous Harry).
The tibial nerve typically bifurcates within the tunnel into the medial plantar nerve, the lateral plantar nerve, and the medial calcaneal branches.
* Medial Plantar Nerve: Passes deep to the abductor hallucis muscle and supplies the medial sole.
* Lateral Plantar Nerve: Travels obliquely across the sole, passing through its own fascial sling, supplying the lateral musculature and skin.
* Medial Calcaneal Nerve: Highly variable; it may branch proximal to the retinaculum, within the tunnel, or from the lateral plantar nerve. It pierces the retinaculum to supply the heel pad.
OPERATIVE TECHNIQUE: PRIMARY TARSAL TUNNEL RELEASE
If surgical treatment is definitively indicated, the procedure must be executed with meticulous precision. The goal is complete, unhindered decompression of the tibial nerve and its terminal branches.
Anesthesia and Positioning
The procedure is typically performed under general or regional anesthesia. The patient is positioned supine with a bump placed under the contralateral hip to allow the operative leg to externally rotate, providing optimal exposure to the medial ankle. A thigh or calf tourniquet is applied to ensure a bloodless surgical field, which is critical for identifying delicate neural structures.
Incision and Superficial Dissection
- Incision: A curvilinear incision is made starting 2 to 3 cm proximal to the medial malleolus, positioned midway between the posterior border of the medial malleolus and the Achilles tendon. The incision curves gently distally and anteriorly, following the course of the nerve toward the navicular tuberosity.
- Superficial Exposure: Subcutaneous tissues are carefully divided. Extreme care must be taken to identify and protect the medial calcaneal nerve branches, which often pierce the retinaculum superficially in this region.
Deep Dissection and Decompression
The tibial nerve and its branches must be meticulously exposed and unroofed. The dissection is refined by the use of surgical loupe magnification, small dissecting scissors, and nontoothed forceps.
- Proximal Release: The surgeon must keep in mind that the flexor retinaculum is a fibrous thickening of the deep investing fascia of the calf proximally. Therefore, the release must include the incision of 1 to 2 cm of the deep fascia above the proximal edge of the flexor retinaculum to prevent a proximal tethering effect.
- Retinacular Release: The flexor retinaculum is divided longitudinally along the course of the nerve. The posterior tibial artery and its branches, along with the accompanying veins (venae comitantes), must be protected. These veins may be numerous, engorged, and frequently overlie the medial and lateral plantar nerves. Careful bipolar electrocautery is used for hemostasis; monopolar cautery is strictly avoided near the nerve.
- Distal Release (The Porta Pedis): The release is not complete until the medial and lateral plantar nerves are followed distally beneath the abductor hallucis muscle. One or both of these branches may pass through dense, independent fascial slings as they enter the plantar surface of the foot. The deep fascia of the abductor hallucis must be divided, and the muscle belly may be partially retracted or released to ensure no distal compression remains. The fibrous septum separating the medial and lateral plantar tunnels should also be excised if it appears constrictive.
Closure
Following complete decompression, the tourniquet is deflated, and meticulous hemostasis is achieved. Hematoma formation within the tarsal tunnel is a primary cause of postoperative scarring and failure. The flexor retinaculum is never repaired, as doing so would recreate the compressive pathology. Only the subcutaneous tissue and skin are closed using interrupted, non-absorbable sutures.
REVISION TARSAL TUNNEL SURGERY
Revision tarsal tunnel release requires even more scrutiny of all clinical factors that can influence a surgical decision. Diagnosing an "inadequate primary release" is notoriously difficult, even with access to the original operative notes. The surgeon must differentiate between incomplete initial decompression, recurrent space-occupying lesions, and irreversible intraneural fibrosis (scarring).
Diagnostic Challenges in Revision
Preoperative advanced imaging (MRI or high-resolution ultrasound) and electromyography/nerve conduction studies (EMG/NCS) are mandatory to assess the continuity of the nerve and the presence of perineural scarring. However, these modalities often cannot definitively predict whether a secondary release will alleviate symptoms.
"Containment" Procedures
In cases of severe perineural fibrosis, simple neurolysis is often insufficient, as the nerve will simply re-adhere to the surrounding scar bed.
Pitfall: "Containment" procedures, such as wrapping the posterior tibial nerve throughout the tarsal tunnel and beyond its boundaries with autologous vein grafts or synthetic collagen conduits, are considered heroic attempts to aid a patient debilitated by chronic pain. However, these techniques are currently lacking in sufficient long-term, multicenter data to be routinely recommended. They should be reserved for salvage situations by peripheral nerve specialists.
POSTOPERATIVE REHABILITATION PROTOCOL
The postoperative protocol is designed to prevent hematoma formation, minimize scar tissue adherence, and gradually restore function.
- Phase 1: Immobilization (Weeks 0-3): The patient is placed in a bulky, compressive Jones dressing and a posterior splint with the ankle in a neutral position. Strict non-weight-bearing status is maintained to allow the skin to heal and prevent early mechanical irritation of the decompressed nerve.
- Phase 2: Early Mobilization (Weeks 3-6): Sutures are typically removed at 14 to 21 days. The patient is transitioned to a controlled ankle motion (CAM) boot. Progressive, partial weight-bearing is initiated. Gentle, active range-of-motion exercises (specifically dorsiflexion and plantarflexion) are encouraged to promote nerve gliding and prevent adherence to the surgical bed.
- Phase 3: Strengthening and Return to Activity (Weeks 6-12): The patient is weaned from the CAM boot into supportive footwear. Physical therapy focuses on intrinsic foot muscle strengthening, proprioception, and gradual return to full functional activities. Maximum medical improvement may not be realized until 6 to 12 months postoperatively.
CONCLUSION
The management of tarsal tunnel syndrome remains one of the more challenging paradigms in foot and ankle surgery. While conservative measures provide relief for a subset of patients, those requiring surgical intervention must be approached with a clear understanding of the anatomical complexities and the historically guarded outcomes. Meticulous surgical technique, encompassing a complete proximal and distal release of the neurovascular bundle, combined with strict patient selection, offers the best opportunity for a successful clinical result. Surgeons must prioritize extensive preoperative counseling to ensure patients have realistic expectations regarding their postoperative recovery and long-term prognosis.
